DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Lagalla G, Millevolte M, Capecci M. et al.
Botulinum toxin type a for drooling in Parkinson’s disease: A
double-blind, randomized, placebo-controlled study.
Mov Disord 2006;
5: 704-707
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.